Home LiteratureArticle Details
PMID: 11698702 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

AIDS (London, England) ·Vol. 15 ·No. 17 ·2001-11-23 ·Pages 2287-92

Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, Perrin L, Swiss HIV Cohort Study

Abstract

To assess the impact of primary HIV infection (PHI) on the spread of HIV and the temporal trends in transmission of HIV drug resistance between 1996 and 1999 in Switzerland. Sequencing of the genes for reverse transcriptase (RT) and protease was performed for 197 individuals with documented PHI. Phylogenetic analyses were confronted with epidemiological data. Significant clustering was demonstrated for 29% of the RT sequences. All these cases occurred closely together in place and time; contact tracing demonstrated transmission at the time of PHI in 30% of them. Genotypic drug resistance was detected in 8.6% of PHI individuals in 1996, 14.6% in 1997, 8.8% in 1998 and 5.0% in 1999. Drug-resistant variants were identified in 11.3% of individuals infected by homosexual contacts, 6.1% by heterosexual contacts, 13% of intravenous drug users and more frequently in men (10.4%) than women (2.6%). Potential factors involved in the recent decrease of transmission of drug-resistant variants include increase of HIV non-B subtypes from 23% in 1996 to 35% in 1999 (only one non-B subtype had resistance mutations) and a steady increase of patients with undetectable viraemia as documented in Swiss HIV Cohort Study (10% in 1996 vs 53% in 1999). Phylogenetic and epidemiological analyses underline the impact of PHI in the spread of HIV. Moreover, this study indicates that drug resistance transmission may have decreased recently in Switzerland through the increased frequency of infection with HIV non-B subtypes and the steady increase of patients with undetectable viraemia.

MeSH Terms
Acute Disease Adolescent Adult Aged Drug Resistance, Viral/genetics Female Genetic Variation HIV Infections/epidemiology,immunology,transmission,virology HIV Protease/genetics HIV Reverse Transcriptase/genetics HIV-1/classification,drug effects,enzymology,genetics Humans Male Middle Aged Phylogeny Switzerland/epidemiology
Chemicals
HIV Reverse Transcriptase HIV Protease
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Yerly S
University Hospital of Geneva, 1211 Geneva 14, Switzerland.
Vora S
Rizzardi P
Chave J P
Vernazza P L
Flepp M
Telenti A
Battegay M
Veuthey A L
Bru J P
Rickenbach M
Hirschel B
Perrin L
Swiss HIV Cohort Study
Article Info
Journal
AIDS (London, England)
Abbr.
AIDS
ISSN
0269-9370
Published
2001-11-23
Pages
2287-92
Language
English
Region
England
NLM ID
8710219
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com